Chorioamnionitis and ontogeny of circulating prostaglandin and thromboxane in preterm infants

American Journal of Perinatology

Volumn 25, Issue 8, 2008, Pages 491-497

  Natarajan, Girija ^a,c   Glibetic, Maria ^a,b   Thomas, Ronald L ^a   Aranda, Jacob V ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Chorioamnionitis; Preterm; Prostaglandin; Thromboxane

Indexed keywords

PROSTAGLANDIN E2; THROMBOXANE;

ADULT; AMNIOCENTESIS; AMNION FLUID; ARTICLE; BIRTH WEIGHT; BLOOD CULTURE; CHORIOAMNIONITIS; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; LIPID BLOOD LEVEL; LUNG DYSPLASIA; MALE; NEWBORN; NEWBORN MORBIDITY; ONTOGENY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIRTH WEIGHT; BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; DINOPROSTONE; FEMALE; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PREGNANCY; PREGNANCY OUTCOME; RESPIRATORY DISTRESS SYNDROME, NEWBORN; THROMBOXANE B2; YOUNG ADULT;

EID: 55449101021     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0028-1085068     Document Type: Article

References (29)

1. Challis JR, Sloboda DM, Alfaidy N, et al. Prostaglandins and mechanisms of preterm birth. Reproduction 2002;124:1-17
2. Agostiniani R, Mariotti P, Cataldi L, et al. Role of renal PGE2 in the adaptation from foetal to extrauterine life in term and preterm infants. Prostaglandins Leukot Essent Fatty Acids 2002;67:373-377
3. Chemtob S, Li DY, Abran D, et al. The role of prostaglandin receptors in regulating cerebral blood flow in the perinatal period. Acta Paediatr 1996;85:517-524
4. Seyberth HW, Kuhl PG. The role of eicosanoids in paediatrics. Eur J Pediatr 1988;147:341-349
5. Seyberth HW, Leonhardt A, Tonshoff B, et al. Prostanoids in paediatric kidney diseases. Pediatr Nephrol 1991;5:639-649
6. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997;42:1-8
7. Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202
8. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177:825-830
9. Curley AE, Sweet DG, MacMahon KJ, et al. Chorioamnionitis increases matrix metalloproteinase-8 concentrations in bronchoalveolar lavage fluid from preterm babies. Arch Dis Child Fetal Neonatal Ed 2004;89:F61-F64
10. Mitchell MD, Bibby JG, Hicks BR, et al. Thromboxane B2 and human parturition: concentrations in the plasma and production in vitro. J Endocrinol 1978;78:435-441
11. Varvarigou A, Bardin CL, Beharry K, et al. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996;275:539-544
12. Viscardi RM, Muhumuza CK, Rodriguez A, et al. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 2004;55:1009-1017
13. Watterberg KL, Demers LM, Scott SM, et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996;97: 210-215
14. Gupta M, Mestan KK, Martin CR, et al. Impact of clinical and histologic correlates of maternal and fetal inflammatory response on gestational age in preterm births. J Matern Fetal Neonatal Med 2007;20:39-46
15. Yang SY, Gao ZX. Determination and clinical significance of plasma levels of prostaglandins in patients with acute brain injury. Surg Neurol 1999;52:238-245
16. Lopez-Herce J, Codoceo R, Delgado MA, et al. Plasma and gastric juice levels of prostaglandins in critically ill children. J Pediatr Gastroenterol Nutr 1992;14:279-282
17. Sood BG, Delaney-Black V, Glibetic M, et al. PGE2/TXB2 imbalance in neonatal hypoxemic respiratory failure. Acta Paediatr 2007;96:669-673
18. Clyman RI, Brett C, Mauray F. Circulating prostaglandin E2 concentrations and incidence of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Pediatrics 1980;66:725-729
19. Kopelman AE, Dombroski D, Engelke SC, et al. Plasma prostaglandin E2 and F2 alpha in preterm infants: association with respiratory distress syndrome and patent ductus arteriosus. Prostaglandins Leukot Med 1983;10:423-431
20. Hammerman C, Zaia W, Berger S, et al. Prostaglandin levels: predictors of indomethacin responsiveness. Pediatr Cardiol 1986;7:61-65
21. Cho S, Beharry KD, Valencia AM, et al. Maternal and fetoplacental prostanoid responses to a single course of antenatal betamethasone. Prostaglandins Other Lipid Mediat 2005;78: 139-159
22. Huang HC, Wang CL, Huang LT, et al. Association of cord blood cytokines with prematurity and cerebral palsy. Early Hum Dev 2004;77:29-36
23. Redline RW, Wilson-Costello D, Hack M. Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res 2002;52: 713-719
24. Le Guennec JC, Lauziere M, Black R, et al. Effects of indomethacin on prostaglandin E2 and thromboxane B2 contents of tracheal lavage fluids in premature infants. Inflammation 1991;15:55-59
25. Strasser T, Vogel M. Prostaglandin E2 in the lung lavage fluid of premature newborns before and after surgical or medical closure of a patent ductus arteriosus. Biochim Biophys Acta 1989;1003:63-66
26. Bashakin NF, Saliaeva MV, Aksenov AN. The functional characteristics of the prostacyclin-thromboxane system in newborn infants with a history of acute and chronic intrauterine hypoxia. Akush Ginekol (Mosk) 1993;(6): 24-27
27. Nishimaki S, Seki K. An imbalance between prostacyclin and thromboxane in relation to cerebral blood flow in neonates with maternal preeclampsia. Prostaglandins Other Lipid Mediat 1999;58:43-49
28. Leonhardt A, Kuhl PG, Schweer H, et al. Pharmacologically active levels of PGE1 in neonates with congenital heart disease. Acta Paediatr Scand 1989;78:853-857
29. Schweer H, Meese CO, Watzer B, et al. Determination of prostaglandin E1 and its main plasma metabolites 15-keto-prostaglandin E0 and prostaglandin E0 by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry. Biol Mass Spectrom 1994;23:165-170